Boston Partners’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
Other funds holding INVA
SFM
SCM
Boston Partners's INVA Position: Q2 2026 in Review
Boston Partners increased its Innoviva (INVA) stake by 12% in Q2 2026, buying an estimated $4.79M and bringing the position to 1,927,959 shares worth $43.8M. The position accounts for 0.04% of the portfolio, ranked #295.
Boston Partners first reported a position in INVA in Q3 2021 and has held it in 19 quarters since. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.
- Boston Partners held 1,927,959 shares of Innoviva worth $43.8M as of Q2 2026.
- Boston Partners bought 209,092 Innoviva shares in Q2 2026, an estimated $4.79M.
- Innoviva made up 0.04% of Boston Partners's portfolio in Q2 2026, its #295 holding.
- Boston Partners first reported a position in Innoviva in Q3 2021 and has held it in 19 quarters since.
- 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.
Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.